Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Genetico reported for 9 months of 2024 by RAS

10/30/24 GECO

Europlan reported for 9 months of 2024 by RAS

10/30/24 LEAS

MD Medical's revenues grew by 22% in 9 months

10/30/24 MDMG

Rosseti Siberia reported for 9 months of 2024 by RAS

10/30/24 MRKS

Zvezda again postpones delivery of Arc7 tankers for Novatek

10/30/24 NVTK

Magadanenergo reported for 9 months of 2024 by RAS

10/30/24 MAGE

Active customer base of VseInstrumenty.ru grew by 4%

10/30/24 VSEH

Sakhalinenergo reported for 9 months of 2024 by RAS

10/30/24 SLEN

En+ Group reported for 9 months of 2024 by RAS

10/29/24 ENPG

Kvant collected the minimum amount of success

10/29/24 OTCI